5Lzumi N, Enomoto N, Uchihara M, et al. Hepaticiron contents and response to interfero-a in patients with chronic hepatitis C [ J]. Dig Dis Sci, 1996,41(5) :989-994.
6Bacon BR,Farahvash MJ,Janney CG, et al. Nonalcoholic steatohepatitis: an expanded clinical entity[ J ]. Gastroenterology, 1994,107 (4):1103-1109.
7Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic induced steatohepatitis: a pilot study[J]: Hepatology, 1996,23( 1 ) :74-80.
8Propst A, Propst T, Judmaier G, et al. Prognosis in nonalcoholic steatohepaitits [letter; comment ] [J]. Gastroenterology, 1995,108(5): 1607.
9Teil MR, James OF, Burt AD, et al. The natural history of nonalcoholic fatty liver: a follow-up study[J]. Hepatology, 1995,22(6): 1714-1719.
8Lee S,Jin Kim Y,YongJeon T,et al.Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fat Gastroenterol.2006,41:566-572.
9Hutton M,Hardy J.The presenilins and Alzheimer' s disease.Hum Mol Genet 1997: 6(10): 1639 -46
10Zekanowski C,Styczynska M,Peplonska B,et al.Mutations in presenilin 1,presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer' s disease in Poland.Exp Neurol 2003; 184(2):991 -6
